NAUT (Nautilus Biotechnology) OCF Margin %: -137,260.00% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NAUT Nautilus Biotechnology Inc NAUT
28 GF Score
Price $0.90
! 3 Warning Signs
View Full Analysis

What is Nautilus Biotechnology OCF Margin %?

Nautilus Biotechnology NAUT +1.44% 28 OCF Margin % is -137,260.00% as of Jun. 2026. GuruFocus rates NAUT with a GF Score™ of 28/100. The stock has 3 warning signs investors should review. Among 953 Biotechnology companies, Nautilus Biotechnology ranks worse than 99.58% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Nautilus Biotechnology's Cash Flow from Operations for the three months ended in Jun. 2026 was $-13.73 Mil. Nautilus Biotechnology's Revenue for the three months ended in Jun. 2026 was $0.01 Mil. Therefore, Nautilus Biotechnology's OCF Margin % for the quarter that ended in Jun. 2026 was -137,260.00%.

As of today, Nautilus Biotechnology's current OCF Yield % is -43.86%.

The historical rank and industry rank for Nautilus Biotechnology's OCF Margin % or its related term are showing as below:

NAUT' s OCF Margin % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: -502350

NAUT's OCF Margin % is ranked worse than
99.58% of 953 companies
in the Biotechnology industry
Industry Median: -63.9 vs NAUT: -502350.00

Nautilus Biotechnology OCF Margin % Related Terms

Nautilus Biotechnology OCF Margin % Historical Data

* Premium members only.

The historical data trend for Nautilus Biotechnology's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nautilus Biotechnology OCF Margin % Chart

Nautilus Biotechnology Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Nautilus Biotechnology Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -137,260.00

NAUT vs SLNCF, CHRS, AVXL: OCF Margin % Comparison

For the Biotechnology subindustry, Nautilus Biotechnology's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nautilus Biotechnology OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nautilus Biotechnology's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Nautilus Biotechnology's OCF Margin % falls into.


NAUT
28GF Score
Nautilus Biotechnology Inc NAUT
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nautilus Biotechnology OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Nautilus Biotechnology's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-50.696/0
= %

Nautilus Biotechnology's OCF Margin for the quarter that ended in Jun. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Jun. 2026 )/Revenue (Q: Jun. 2026 )
=-13.726/0.01
=-137,260.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -137,260.00% mean?
Nautilus Biotechnology (NAUT) has a OCF Margin % of -137,260.00% as of Jun. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Nautilus Biotechnology and its competitors. According to the industry distribution chart, Nautilus Biotechnology ranks #949 out of 953 companies in the Biotechnology industry, placing it in the top 99.6%.
Is Nautilus Biotechnology's OCF Margin % too high?
Nautilus Biotechnology's current OCF Margin % is -137,260.00%. Based on the distribution chart, Nautilus Biotechnology ranks #949 out of 953 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Nautilus Biotechnology has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Nautilus Biotechnology's OCF Margin % compare to SLNCF and CHRS?
According to the Biotechnology industry distribution chart, Nautilus Biotechnology ranks #949 out of 953 companies for OCF Margin %. This places Nautilus Biotechnology in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Nautilus Biotechnology and its competitors. Nautilus Biotechnology's current OCF Margin % is -137,260.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nautilus Biotechnology stock overvalued right now?
Nautilus Biotechnology (NAUT) has a current OCF Margin % of -137,260.00%. The current OCF Margin % is -137,260.00%. Nautilus Biotechnology's overall GF Score™ is 28/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Nautilus Biotechnology (NAUT), the current OCF Margin % is -137,260.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nautilus Biotechnology Business Description

Address 2701 Eastlake Avenue East, Seattle, WA, USA, 98102
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
28GF Score

Get the complete analysis for NAUT

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.90
Price